Skip to main content

Lisinopril

NDC 50090-2228 · A-S Medication Solutions

Generic nameLisinopril
Dosage formTABLET
RouteORAL
Active ingredient(s)LISINOPRIL
Strength5 mg/1
Pharmacologic classAngiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]
Marketing categoryANDA

Packages

50090-2228-0 — 30 TABLET in 1 BOTTLE (50090-2228-0)

50090-2228-3 — 90 TABLET in 1 BOTTLE (50090-2228-3)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

43547-356 — Lisinopril, 43547-414 — Lisinopril, 43547-415 — Lisinopril, 43547-416 — Lisinopril, 43547-417 — Lisinopril, 43547-418 — Lisinopril, 43547-419 — Lisinopril, 43547-420 — Lisinopril and Hydrochlorothiazide Tablets, 43547-421 — Lisinopril and Hydrochlorothiazide Tablets, 43547-422 — Lisinopril and Hydrochlorothiazide Tablets, 50090-2431 — Lisinopril, 50090-2565 — Lisinopril and Hydrochlorothiazide, 50090-2934 — Lisinopril, 50090-2974 — Lisinopril and Hydrochlorothiazide, 50090-3175 — Lisinopril, 50090-3763 — Lisinopril, 50090-3765 — Lisinopril, 50090-3774 — Lisinopril, 50090-4725 — Lisinopril, 50090-4885 — Lisinopril, +342 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels